POSTER SESSION I Monday, February 13, 2006   —  9:30 AM - 12:00 Noon Exhibit Level GYNECOLOGIC PATHOLOGY 103 Volume Of Borderline Change In Ovarian Neoplasms: Do Cystadenomas With Focal Borderline Change Warrant A Full Operative Staging? (789) KA Allison, EM Swisher, RL Garcia - University of Washington Medical Center, Seattle, WA 104 Osteopontin (OPN) Is Colocalized With The Adhesion Molecule CEACam1 In The Extravillous Trophoblast Of The Normal Placenta And In Gestational Trophoblastic Diseases And Enhances Invasion Of CEACam1-Expressing Placental Cells (798) J Briese, M Oberndorfer, C Petschnik, HM Schulte, A Makrigiannakis, T Loning, am Bamberger - University Clinic Hamburg-Eppendorf, Hamburg, Germany; University Crete, Heracleon, Greece 105 The Origin and Spatial Distribution of Chromosome 7q Deletion and Its Association with Tumor Growth in Large Uterine Leiomyomata (804) H Chen, ZM Budimlija, XM Zhang, MK Prinz, MA Perle, JJ Wei - New York University School of Medicine, Medical Examiners Office, New York, NY 106 Endometrial Hyperplasia In Endometrial Polyps: Clinico-Pathologic And Follow-Up Findings (811) D da Costa, K Mittal - New York University School of Medicine, New York, NY 107 An Immunohistochemical Comparison of Ovarian Cancers tested for Germline BRCA1/BRCA2 Mutations (814) B Djordjevic, A Tone, H Begley, J Murphy, B Rosen, J McLaughlin, S Narod, PA Shaw - University of Toronto, Toronto, ON, Canada 108 Reevaluation Of Cervical Biopsies Diagnosed As Low Grade SILs By H&E And HPV In Situ Hybridization (823) RL Fleshman, D Schubert, GJ Nuovo - Ohio State University Medical Center, Columbus, OH 109 Adequacy And Follow-up in Patients With Indeterminate Endometrial Sampling (827) MA Galan, YB Kim, JL Hecht - Beth Israel Deaconess Medical Center, Boston, MA 110 Increased Activity of IGF Signaling in Uterine Leiomyomas (835) EY Han, L Chiriboga, H Yee, K Mittal, JJ Wei - New York University School of Medicine, New York, NY 111 Immunohistochemical Analysis of Intermediate Trophoblastic Tumors (850) N Kalhor, P Ramirez, M Deavers, A Malpica, EG Silva - MD Anderson Cancer Center, University of Texas Health Science Center at Houston Medical School, Houston, TX 112 High Throughput Tissue Microarray for Analysis of Slug and E-Cadherin in Ovarian Serous Neoplasia (855) LA Kubba, T Do, TK Woodruff, KW Lannert, R Orr, H Du, LW Klatzco, G Rodriguez, CD Sturgis - Evanston Northwestern Healthcare, Northwestern University, Evanston, IL; Northwestern University Feinberg School of Medicine, Chicago, IL 113 MicroRNA Profiling Reveals Distinct Signatures In Uterine Leiomyomas (858) L Laura Obijuru, T Wang, P Soteropoulos, J J Wei - New York University, New York, NY; Public Health Research Institute, Newark, NJ 114 High Prevalence Of Cutaneous HPV In Spontaneous Abortions (859) HW Lee, JS Ross, A Rohwedder, JA Carlson - Albany Medical College, Albany, NY; Bio-Med-Mol-Serv, Kalkar, Germany 115 Clonality Of Borderline And Serous Carcinoma Of The Ovary: Molecular Studies Identify A Monoclonal Origin For Primary Tumors And Their Implants (867) EML Li Ning, LS Teller, RSJ Ricketts, C Otis, M Sobel, MJ Merino - National Cancer Institute/National Institutes of Health, Bethesda, MD; Baystate Medical Center Tufts University School of Medicine, Springfield, MA 116 Intestinal and Endocervical-Like Ovarian Mucinous Neoplasms Are Immunophenotypically Distinct Entities (869) X Lin, YL Liu, RS Saad, JF Silverman - Allegheny General Hospital, Pittsburgh, PA 117 A Proposed Protocol for Sectioning and Extensively Examining the Fimbriated End of the Fallopian Tube (SEE-FIM): Implications for Detecting Tubal Epithelial Abnormalities in Women with and Without BRCA Mutations. (876) F Medeiros, Y Lee, MG Muto, JA Elvin, EM Prusak, CP Crum - Brigham and Women's Hospital, Boston, MA; Brigham and Women's Hospital, Boston, MA 118 Glucose Transporter-1 Expression in Endocervical Neoplasia (904) SA Rosen, S Lathrop, A Chakerian, NE Joste - University of New Mexico School of Medicine, Albuquerque, NM 119 Smoking Increases the Risk of High-Grade Vaginal Intraepithelial Neoplasia in Women with Oncogenic Human Papillomavirus (908) JF Sherman, MF Evans, SL Mount, J Skelly, GH Eltabbakh - Fletcher Allen Health Care, University of Vermont, Burlington, VT 120 Tissue Microarray Analysis of Annexin I, Gelsolin, p53, and BRCA1 Supports the Two-Pathway Theory of Ovarian Serous Carcinoma (920) P Soung, J Chan, D Seligson, J Berek, J Rao - UCLA Medical Center, Los Angeles, CA 121 Primary Adenocarcinoma (Other Than Clear Cell Type) Of The Vagina: A Clinicopathologic Study Of 31 Cases (921) PN Staats, PB Clement, RH Young - Massachusetts General Hospital, Boston, MA; Vancouver General Hospital, Vancouver, BC, Canada 122 Pathogenetic Pathways In Ovarian Endometrioid Adenocarcinoma: A Molecular Study Of 29 Cases. (926) J Turbiner, C Sanchez, D Sarrio, G Moreno, I Franceschetti, J Palacios, E Oliva - Massachusetts General Hospital, Boston, MA; CNIO, Madrid, Spain 123 The Utility Of Tumor Cell Necrosis In The Diagnosis Of Primary Leiomyosarcoma Of The Uterus: An Analysis Of 77 Cases. (932) WL Wang, RA Soslow, GF Zannoni, P Branton, D Nonaka, E Oliva - Massachusetts General Hospital, Boston, MA; Memorial Sloan Kettering Cancer Center, New York, NY; Universita Cattolica, Rome, Italy; Inova Fairfax Hospital, Church Falls, VA 124 Immunohistochemical (IHC) Analysis of Sox9 in Ovarian Sertoli Cell Tumors and Other Tumors in the Differential Diagnosis (DDx) (946) C Zhao, GL Bratthauer, R Barner, R Vang - Armed Forces Institute of Pathology, Washington, DC; LAC+USC Medical Center, Los Angeles, CA; Johns Hopkins Hospital, Baltimore, MD